Global Bleeding Disorders Treatment Market 2018: Forecasts & Opportunities to 2023 - ResearchAndMarkets.com

DUBLIN--()--The "Bleeding Disorders Treatment Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023" report has been added to ResearchAndMarkets.com's offering.

The report predicts the global bleeding disorders treatment market to grow with a CAGR of 8.5% over the forecast period of 2017-2023. The study on bleeding disorders treatment market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2015 to 2023.

The report on bleeding disorders treatment market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global bleeding disorders treatment market over the period of 2015 to 2023.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global bleeding disorders treatment market over the period of 2015 to 2023. Further, Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Key Topics Covered

1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

2. Executive Summary

3. Global Bleeding Disorders Treatment Market Overview

3.1. Introduction

3.2. Market Dynamics

3.3. Porter's Five Forces Analysis

3.4. Growth Matrix Analysis

3.5. Competitive Landscape in the Global Bleeding Disorders Treatment Market

4. Global Bleeding Disorders Treatment Market by Type

4.1. Hemophilia A

4.2. Hemophilia B

4.3. Von Willebrand Disease

4.4. Others

5. Global Bleeding Disorders Treatment Market by Drug Class

5.1. Plasma-derived Coagulation Factor Concentrates

5.2. Recombinant Coagulation Factor Concentrates

5.3. Desmopressin

5.4. Antifibrinolytics

5.5. Fibrin Sealants

5.6. Others

6. Global Bleeding Disorders Treatment Market by Region 2017-2023

6.1. North America

6.2. Europe

6.3. Asia-Pacific

6.4. RoW

7. Company Covered

7.1. Baxalta

7.2. Bayer Pharmaceuticals

7.3. Novo Nordisk A/S

7.4. Pfizer Inc.

7.5. Biogen Idec

7.6. CSL Behring

7.7. Grifols

7.8. Octapharma

7.9. Alnylam Pharmaceuticals

7.10. Xenetic Biosciences, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/q8vb7g/bleeding?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Hematology

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Hematology